Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$3.1 - $6.8 $46,810 - $102,680
15,100 New
15,100 $70,000
Q4 2022

Feb 07, 2023

SELL
$2.17 - $35.84 $15,732 - $259,840
-7,250 Reduced 32.44%
15,100 $53,000
Q3 2022

Nov 08, 2022

SELL
$18.3 - $37.02 $59,658 - $120,685
-3,260 Reduced 12.73%
22,350 $827,000
Q2 2022

Aug 05, 2022

BUY
$16.5 - $30.34 $422,565 - $777,007
25,610 New
25,610 $486,000

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.